Merck & Co., Inc.
Merck & Co., Inc. MRK Peers
See (MRK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MRK | $78.79 | -0.05% | 198.4B | 11.48 | $6.88 | +4.08% |
| LLY | $778.93 | -2.04% | 735B | 63.31 | $12.25 | +0.72% |
| AZN | $69.66 | -0.59% | 433.1B | 28.16 | $2.48 | +2.21% |
| JNJ | $151.97 | -0.02% | 366.7B | 16.95 | $8.99 | +3.30% |
| ABBV | $185.34 | -0.78% | 322.2B | 77.94 | $2.34 | +3.46% |
| NVO | $68.72 | +1.51% | 303.3B | 18.87 | $3.63 | +2.36% |
| NVS | $120.96 | +0.53% | 237.1B | 18.82 | $6.38 | +3.33% |
| AMGN | $278.83 | -0.10% | 149B | 25.23 | $10.98 | +3.35% |
| GILD | $110.85 | +3.00% | 137.7B | 14.30 | $7.74 | +2.83% |
| PFE | $24.27 | +0.12% | 137.5B | 17.53 | $1.38 | +7.04% |
Stock Comparison
MRK vs LLY Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, LLY has a market cap of 735B. Regarding current trading prices, MRK is priced at $78.79, while LLY trades at $778.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas LLY's P/E ratio is 63.31. In terms of profitability, MRK's ROE is +0.38%, compared to LLY's ROE of +0.77%. Regarding short-term risk, MRK is less volatile compared to LLY. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs AZN Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, AZN has a market cap of 433.1B. Regarding current trading prices, MRK is priced at $78.79, while AZN trades at $69.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas AZN's P/E ratio is 28.16. In terms of profitability, MRK's ROE is +0.38%, compared to AZN's ROE of +0.19%. Regarding short-term risk, MRK is more volatile compared to AZN. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs JNJ Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, JNJ has a market cap of 366.7B. Regarding current trading prices, MRK is priced at $78.79, while JNJ trades at $151.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas JNJ's P/E ratio is 16.95. In terms of profitability, MRK's ROE is +0.38%, compared to JNJ's ROE of +0.30%. Regarding short-term risk, MRK is more volatile compared to JNJ. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs ABBV Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, ABBV has a market cap of 322.2B. Regarding current trading prices, MRK is priced at $78.79, while ABBV trades at $185.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas ABBV's P/E ratio is 77.94. In terms of profitability, MRK's ROE is +0.38%, compared to ABBV's ROE of +0.96%. Regarding short-term risk, MRK is less volatile compared to ABBV. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs NVO Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, NVO has a market cap of 303.3B. Regarding current trading prices, MRK is priced at $78.79, while NVO trades at $68.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas NVO's P/E ratio is 18.87. In terms of profitability, MRK's ROE is +0.38%, compared to NVO's ROE of +0.81%. Regarding short-term risk, MRK is less volatile compared to NVO. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs NVS Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, NVS has a market cap of 237.1B. Regarding current trading prices, MRK is priced at $78.79, while NVS trades at $120.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas NVS's P/E ratio is 18.82. In terms of profitability, MRK's ROE is +0.38%, compared to NVS's ROE of +0.31%. Regarding short-term risk, MRK is more volatile compared to NVS. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs AMGN Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, AMGN has a market cap of 149B. Regarding current trading prices, MRK is priced at $78.79, while AMGN trades at $278.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas AMGN's P/E ratio is 25.23. In terms of profitability, MRK's ROE is +0.38%, compared to AMGN's ROE of +0.93%. Regarding short-term risk, MRK is more volatile compared to AMGN. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs GILD Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, GILD has a market cap of 137.7B. Regarding current trading prices, MRK is priced at $78.79, while GILD trades at $110.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas GILD's P/E ratio is 14.30. In terms of profitability, MRK's ROE is +0.38%, compared to GILD's ROE of +0.32%. Regarding short-term risk, MRK is less volatile compared to GILD. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs PFE Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, PFE has a market cap of 137.5B. Regarding current trading prices, MRK is priced at $78.79, while PFE trades at $24.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas PFE's P/E ratio is 17.53. In terms of profitability, MRK's ROE is +0.38%, compared to PFE's ROE of +0.09%. Regarding short-term risk, MRK is more volatile compared to PFE. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs SNY Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, SNY has a market cap of 116.6B. Regarding current trading prices, MRK is priced at $78.79, while SNY trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas SNY's P/E ratio is 16.61. In terms of profitability, MRK's ROE is +0.38%, compared to SNY's ROE of +0.08%. Regarding short-term risk, MRK and SNY have similar daily volatility (1.27).
MRK vs BMY Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, BMY has a market cap of 94.3B. Regarding current trading prices, MRK is priced at $78.79, while BMY trades at $46.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas BMY's P/E ratio is 17.28. In terms of profitability, MRK's ROE is +0.38%, compared to BMY's ROE of +0.32%. Regarding short-term risk, MRK is more volatile compared to BMY. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs CELG-RI Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, CELG-RI has a market cap of 84.1B. Regarding current trading prices, MRK is priced at $78.79, while CELG-RI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, MRK's ROE is +0.38%, compared to CELG-RI's ROE of +0.32%. Regarding short-term risk, MRK is less volatile compared to CELG-RI. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs GSK Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, GSK has a market cap of 78.9B. Regarding current trading prices, MRK is priced at $78.79, while GSK trades at $38.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas GSK's P/E ratio is 18.90. In terms of profitability, MRK's ROE is +0.38%, compared to GSK's ROE of +0.22%. Regarding short-term risk, MRK and GSK have similar daily volatility (1.27).
MRK vs HZNP Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, HZNP has a market cap of 26.6B. Regarding current trading prices, MRK is priced at $78.79, while HZNP trades at $116.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas HZNP's P/E ratio is 61.86. In terms of profitability, MRK's ROE is +0.38%, compared to HZNP's ROE of +0.11%. Regarding short-term risk, MRK is more volatile compared to HZNP. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs BIIB Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, BIIB has a market cap of 18.5B. Regarding current trading prices, MRK is priced at $78.79, while BIIB trades at $124.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas BIIB's P/E ratio is 12.46. In terms of profitability, MRK's ROE is +0.38%, compared to BIIB's ROE of +0.09%. Regarding short-term risk, MRK is less volatile compared to BIIB. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs GRFS Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, GRFS has a market cap of 7.4B. Regarding current trading prices, MRK is priced at $78.79, while GRFS trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas GRFS's P/E ratio is 32.81. In terms of profitability, MRK's ROE is +0.38%, compared to GRFS's ROE of +0.03%. Regarding short-term risk, MRK is less volatile compared to GRFS. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs OGN Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, OGN has a market cap of 2.6B. Regarding current trading prices, MRK is priced at $78.79, while OGN trades at $9.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas OGN's P/E ratio is 3.42. In terms of profitability, MRK's ROE is +0.38%, compared to OGN's ROE of +1.82%. Regarding short-term risk, MRK is less volatile compared to OGN. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs CTOR Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, CTOR has a market cap of 322M. Regarding current trading prices, MRK is priced at $78.79, while CTOR trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas CTOR's P/E ratio is -11.84. In terms of profitability, MRK's ROE is +0.38%, compared to CTOR's ROE of -0.15%. Regarding short-term risk, MRK is less volatile compared to CTOR. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs SCLX Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, SCLX has a market cap of 42.1M. Regarding current trading prices, MRK is priced at $78.79, while SCLX trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas SCLX's P/E ratio is -0.40. In terms of profitability, MRK's ROE is +0.38%, compared to SCLX's ROE of +0.36%. Regarding short-term risk, MRK is less volatile compared to SCLX. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs SCLXW Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, SCLXW has a market cap of 36.3M. Regarding current trading prices, MRK is priced at $78.79, while SCLXW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas SCLXW's P/E ratio is N/A. In terms of profitability, MRK's ROE is +0.38%, compared to SCLXW's ROE of +0.36%. Regarding short-term risk, MRK is more volatile compared to SCLXW. This indicates potentially higher risk in terms of short-term price fluctuations for MRK.
MRK vs MIRA Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, MIRA has a market cap of 21.1M. Regarding current trading prices, MRK is priced at $78.79, while MIRA trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas MIRA's P/E ratio is -2.65. In terms of profitability, MRK's ROE is +0.38%, compared to MIRA's ROE of -3.41%. Regarding short-term risk, MRK is less volatile compared to MIRA. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs SRXH Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, SRXH has a market cap of 6.8M. Regarding current trading prices, MRK is priced at $78.79, while SRXH trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas SRXH's P/E ratio is N/A. In terms of profitability, MRK's ROE is +0.38%, compared to SRXH's ROE of -0.50%. Regarding short-term risk, MRK is less volatile compared to SRXH. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.
MRK vs CRXT Comparison
MRK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MRK stands at 198.4B. In comparison, CRXT has a market cap of 0. Regarding current trading prices, MRK is priced at $78.79, while CRXT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MRK currently has a P/E ratio of 11.48, whereas CRXT's P/E ratio is -0.02. In terms of profitability, MRK's ROE is +0.38%, compared to CRXT's ROE of -4.63%. Regarding short-term risk, MRK is less volatile compared to CRXT. This indicates potentially lower risk in terms of short-term price fluctuations for MRK.